Case report
Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome

https://doi.org/10.1016/0887-8994(95)00082-QGet rights and content

Abstract

Large-scale mitochondrial DNA deletion was found in a 5-year-old girl with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome. Muscle biopsy disclosed ragged-red fibers and cytochrome c oxidase negative fibers. Respiratory chain studies were normal. Southern blot analysis demonstrated a 10.5-Kb heteroplasmic deletion in both muscle and blood. Deleted genomes represented 40% of total mitochondrial DNA in muscle and 63% in blood. There was no evidence of point mutations characteristic of MELAS. We suggest that not only patients with progressive external ophthalmoplegia syndromes, but also those with defined syndromes [e.g., MELAS or myoclonic epilepsy and ragged-red fibers (MERRF)] without characteristic point mutations, be screened for mitochondrial DNA deletions.

References (15)

There are more references available in the full text version of this article.

Cited by (45)

  • The neuro-ophthalmology of mitochondrial disease

    2010, Survey of Ophthalmology
    Citation Excerpt :

    Heteroplasmic point mutations in mtDNA account for the bulk of cases of MELAS; however, large-scale mtDNA deletions causing MELAS have also been reported, usually as part of a more general overlap syndrome. MELAS/KSS and MELAS/Fanconi syndrome are two such overlap syndromes attributable to large-scale deletions in mtDNA,26,263 highlighting the importance of searching for mtDNA deletions when testing for point mutations is negative. MELAS mutations result in deficient expression of mitochondrial respiratory chain proteins and impaired OXPHOS.

  • The Fanconi Syndrome

    2009, Genetic Diseases of the Kidney
  • The in-depth evaluation of suspected mitochondrial disease

    2008, Molecular Genetics and Metabolism
  • Mitochondrial encephalomyopathies

    2007, Handbook of Clinical Neurology
    Citation Excerpt :

    However, there are at least 12 other distinct pathogenic mtDNA gene mutations associated with the MELAS phenotype (Iizuka et al., 2002). These include mutations at position 3271 (Goto et al., 1991) and 3291 (Goto et al., 1994) in the tRNALeu gene, the T3308C mutation in the ND1 gene (Campos et al., 1997), various ND5 gene mutations (Liolitsa et al., 2003), the T9957C point mutation in the CO III gene (Manfredi et al., 1995) and large‐scale deletions (Campos et al., 1995). MELAS syndrome is one of the most frequently occurring mitochondrial diseases.

  • Renal manifestations of congenital lactic acidosis

    2002, American Journal of Kidney Diseases
    Citation Excerpt :

    There were no statistically significant relationships among these variables. We compared findings in our 35 patients with data from an additional 79 published reports9-62 of patients with deficiencies of either the PDC or respiratory chain (including mitochondrial DNA mutations; Tables 4 and 5). Frequencies of Abnormal Serum Indices of Renal Function in Patients With PDC or Respiratory Chain Deficiency

View all citing articles on Scopus
View full text